Special Series: Obesity and GLP-1 Medications
Topics covered in this series
Welcome to the Obesity and GLP-1 Medications Special Series
In this series, you will find:
- A letter from our guest editor and the editors of Perspectives
- Information about an upcoming virtual event
- Special series articles (Articles will be published on a rolling basis throughout March 2025)
- Series Editors
- Sign up for article alerts
Letter from guest editor Wudeneh Mulugeta, MD, MPH
Published March 2025
We wish to acknowledge the complexity of the term “obesity” and language around this topic. “Obesity” is a medical diagnosis based on body mass index, which identifies people as having this medical condition based solely on their body size and has significant shortcomings as a clinical tool. Different terms may be preferred by individuals, including “fat,” “overweight,” “big,” “heavy,” “higher-weight,” “unhealthy weight,” and others. Unsurprisingly, this is an area of debate both within medicine and in the general public. However, it is important to note that the word “obesity is felt by many to be stigmatizing, and that many people at higher weights have experienced bias and discrimination not just by society at large, but by medical professionals. Some also feel that World Obesity Day itself perpetuates weight bias and stigma. In putting together this special issue, it is not our intent to contribute to this stigma, only to contribute to knowledge. Please reach out to the editorial team if you have any concerns, and we welcome articles with differing perspectives by all readers regardless of background.
For more reading on the language and advocacy around these issues, we recommend the following:
- Lancet Commission reexamining the clinical importance and diagnosis of obesity
- Words are heavy: Weight-related terminology preferences are associated with larger-bodied people’s health behaviors and beliefs
- "Fat is Not the Problem—Fat Stigma Is" by L. Bacon & A. Severson
Join us for a virtual event
Friday, March 28, 10-11 a.m. ET
As GLP-1 and GLP-1/GIP receptor agonist use becomes more common, it is important to stay up to date on the latest clinical guidance. During this virtual event, we will talk with a primary care physician who is board-certified in obesity medicine, a pediatric endocrinologist, and a clinical psychologist to cover different aspects of obesity medicine and best practices GLP-1 medication use.
Special series articles
Please note these articles will be published on a rolling basis throughout March 2025. To receive a notification of new articles, sign up for alerts at the bottom of this page.
Clinical Considerations
Update in weight management within primary care in the era of GLP-1
Learn the latest guidelines for Primary Care
Article By: Wudeneh Mulugeta, MD, MPH
Mental Health
Forthcoming
Equity
Forthcoming
Personal Perspective
Forthcoming
Misinformation
Forthcoming